ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2004–2021
Source type
Journal
Open access
No
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Drug Discovery Today: Technologies
Drug Discovery Today: Technologies is not currently indexed in Scopus. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 1740-6749Verify ISSN ↗
Publisher: Elsevier Ltd
Scopus · InactiveONOS
0
Indexed in
Cost to publish: About US$3,900 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Drug Discovery Today: Technologies indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2004–2021).
What is the impact factor of Drug Discovery Today: Technologies?
Drug Discovery Today: Technologies has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
How much does it cost to publish in Drug Discovery Today: Technologies?
The publisher lists an article processing charge of about US$3,900 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Drug Discovery Today: Technologies and what is its ISSN?
Drug Discovery Today: Technologies is published by Elsevier Ltd. Its ISSN is 1740-6749.
Is Drug Discovery Today: Technologies covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Drug Discovery Today: Technologies in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Drug Discovery Today: Technologies open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Drug Discovery Today: Technologies for 18 years, between 2004 and 2021. Coverage ended in 2021, 5 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 671 works and 30,240 citations for the title. Its most recent paper is from 2021, in line with the end of Scopus coverage in 2021, which suggests the journal stopped publishing around then.
How well cited is Drug Discovery Today: Technologies? — open metrics via OpenAlex
Drug Discovery Today: Technologies has an h-index of 78 and a 2-year mean of 0 citations per paper (OpenAlex).
78
h-index
0
2-yr mean citations
431
i10-index
671
works indexed
30,240
total citations
Publication fee · open access list price, US$
US$3,900
Drug Discovery Today: Technologies published 24 papers in 2021; its busiest recent year was 2012 with 72. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in Drug Discovery Today: Technologies? — latest 22 articles, 2021
In its latest 22 research articles (2021), authors are most often from United States (36.4%), Netherlands (11.4%) and Hungary (9.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Drug Discovery Today: Technologies? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2021. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2021
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Elsevier Ltd
Elsevier Ltd has 598 other titles in our data; 507 are currently indexed in Scopus.
Related journals
8 journals Journal Indexed in
Drug Discovery Today: Therapeutic Strategies Not in these indexes e-Prime - Advances in Electrical Engineering, Electronics and Energy Scopus Q1 DOAJ e-Prime - Nexus of Electrical, Electronic, and Intelligent Engineering Not in these indexes e-SPEN Not in these indexes e-SPEN Journal Not in these indexes Early Childhood Research Quarterly Scopus Q1 WoS SSCI Eating Behaviors Scopus Q2 WoS SSCI eClinicalMedicine Scopus Q1 WoS SCIE DOAJ
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.